See what’s new.
Duke Inventions Bring $82.6M in Revenue and Launch 6 New Start-Ups
$82.6M in revenue. 94 patents issued. 302 new invention disclosures. In a down year for new disclosures, OTC focuses on investing in the future.
Adaptin Bio Announces FDA Clearance of IND Application for APTN-101 in Glioblastoma
Adaptin Bio is a Duke start-up based around glioblastoma-related technologies developed in the lab of Dr. John Sampson (Neurosurgery, SOM).
New therapy for glioma receives FDA approval, leveraging cancer research conducted at Johns Hopkins & Duke University
Drs. Darell Bigner and Hai Yan (Neurosurgery, SOM) and colleagues identified the genetic mutation targeted by this new drug. Dr. Katherine Peters (Neurosurgery, SOM) was lead investigator in the clinical trials.
VQ Biomedical receives $750K grant from BARDA / ASPR / HHS
VQ Biomedical is a start-up resulting from the collaboration of Assistant Professor Tobias Straube (Pediatrics, SOM) and Research Scientist Stewart Farling (CEE, Pratt).
Triangle Universities Startup Workshop: Academic Entrepreneurs Get an Intensive Course in Venture
What does it take to build a therapeutic or medical device startup? Duke, UNC, and NC State – with support from Alexandria Venture Investments – put on a three-day workshop for a select group of…
Meta Marketplace – Duke Magazine
Ideas from the lab of David Smith (ECE, Pratt) are showing up all over the place. Learn more about the lab's multiple spinouts.
Weird Science – Duke Magazine
Professor David Smith (ECE, Pratt) is a pioneer in the field of metamaterials – melding basic research and successful commercialization.
ARVO recognizes Daniel R. Saban as a rising star in the world of ophthalmology and visual science
Leading research organization awards Associate Professor Daniel R. Saban (Ophthalmology, SOM) for his contributions to the field. Saban is commercializing this research through Duke University start-up Piximune Therapeutics.
Oak Ridge National Laboratory Collaborates with IonQ to Drive Critical U.S. Infrastructure Improvements
ORNL will leverage Duke start-up IonQ’s quantum technology to help solve power grid challenges in the U.S.